Immunogenicity Study of the Influenza Vaccine in Adults

Clinical trial NCT00258934 · COMPLETED

Trial details

NCT number: NCT00258934
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Orthomyxoviridae Infections Influenza

Start date: 2005-09-01
Primary completion: 2008-06-01
Enrollment: 978

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.